Mar 29, 2026SGLT2 Inhibitors vs GLP-1 Drugs: Kidney Study ResultsSGLT2 inhibitors beat GLP-1 drugs on some kidney outcomes, but mortality and albuminuria complicate the choice. What the first head-to-head study found today.sglt2 inhibitorsglp-1 receptor agoniststype 2 diabetesRead article →